Mycoplasma Contamination: Understanding The Risks And Taking On The Challenges

Source: Parker Bioscience

By Guy Matthews and Dr Carolyn Heslop

Human Cell 450x300

Mycoplasma contamination events, although rare, can have an enormous and immediate negative impact on biomanufacturers leading to reduced productivity and delays in products reaching patients.

Here presenters Guy Matthews, global market development manager, and Dr. Carolyn Heslop, technical support group team leader, answer common questions on the threat posed by Mycoplasma contamination and how this can be tackled by biopharmaceutical manufacturers.